ABL Diagnostics
Research ABL Diagnostics (ABLD.PA) on Bullrun: market cap EUR 38.89M, P/E 40.3, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerABLD.PA
- ExchangeXPAR
- CountryFrance
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyEUR
- Market capEUR 38.89M
- P/E40.3
- Dividend yield4.4%
- Financial periodFY2025
- RevenueEUR 6.95M
- Revenue growth30.4%
- Net incomeEUR 986.70K
- Free cash flowEUR 714.76K
- Gross margin95.3%
Valuation Snapshot
latest market cap is EUR 38.89M; P/E is 40.3; dividend yield is 4.4%.
Peer valuation comparison
Latest P/E is 40.33x versus a Healthcare sector median of 23.44x (72.1% above).
Latest dividend yield is 4.44% versus a Healthcare sector median of 2.1% (111.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 6.95M | EUR 986.70K | EUR 714.76K | 95.3% | n/a | EUR 1.08M | EUR 2.25M | EUR 7.63M |
| FY2024 | EUR 5.33M | EUR 285.17K | -EUR 2.32M | 90.7% | 0.02 | EUR 468.78K | EUR 2.55M | EUR 7.49M |
| FY2023 | EUR 5.61M | EUR 54.36K | n/a | 86.9% | 0 | EUR 2.22M | EUR 3.47M | EUR 6.77M |
| FY2022 | EUR 8.75M | EUR 1.11M | n/a | 95.1% | 0.07 | EUR 1.01M | EUR 2.66M | EUR 6.75M |
| FY2021 | n/a | n/a | -EUR 56.69K | n/a | 0.13 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-05 | EUR 38.89M | 40.3 | 4.6% | 0.11 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.11 EUR, yield 4.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.05 EUR |
About ABL Diagnostics
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ABL Diagnostics's market cap?
ABL Diagnostics's market capitalization is EUR 38.89M.
What is ABL Diagnostics's P/E ratio?
ABL Diagnostics's price-to-earnings (P/E) ratio is 40.3.
Does ABL Diagnostics pay a dividend?
ABL Diagnostics has a dividend yield of 4.4%.
What does ABL Diagnostics do?
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally.